Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer

被引:0
|
作者
Yuri Kimura
Shinsuke Sasada
Akiko Emi
Norio Masumoto
Takayuki Kadoya
Morihito Okada
机构
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
来源
Supportive Care in Cancer | 2021年 / 29卷
关键词
Breast cancer; Primary prophylactic G-CSF; Febrile neutropenia; TC chemotherapy; Relative dose intensity; Hospitalization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3507 / 3512
页数:5
相关论文
共 50 条
  • [1] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [2] Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
    Sakurada, Takumi
    Bando, Sanako
    Zamami, Yoshito
    Takechi, Kenshi
    Chuma, Masayuki
    Goda, Mitsuhiro
    Kirino, Yasushi
    Nakamura, Toshimi
    Teraoka, Kazuhiko
    Morimoto, Masami
    Tangoku, Akira
    Ishizawa, Keisuke
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (05) : 1107 - 1114
  • [3] Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
    Takumi Sakurada
    Sanako Bando
    Yoshito Zamami
    Kenshi Takechi
    Masayuki Chuma
    Mitsuhiro Goda
    Yasushi Kirino
    Toshimi Nakamura
    Kazuhiko Teraoka
    Masami Morimoto
    Akira Tangoku
    Keisuke Ishizawa
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1107 - 1114
  • [4] Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
    Advani, S. H.
    Achreckar, Suvarna
    Thomas, Dennis
    Krishnankutty, Binny
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2010, 31 (03) : 79 - 82
  • [5] Impact of granulocyte-colony stimulating factor on docetaxel-induced febrile neutropenia in patients with breast cancer
    Zekri, Jamal
    Nawaz, Azhar
    Rasool, Haleem
    Ahmad, Imran
    Abdel Rahman, Hossam
    Dada, Reyad
    Abdelghany, Ehab Mosaad
    Farag, Kamel
    Ibrahim, Refaei Belal
    Deibas, Mohamed Youssef
    Kamel, Mohamed Kamal
    Allithy, Ahmed
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1681 - 1686
  • [6] Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D
    Lee, Esther K.
    Wong, William W. L.
    Trudeau, Maureen E.
    Chan, Kelvin K. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 169 - 180
  • [7] Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors
    Timmer-Bonte, Johanna N. H.
    Tjan-Heijnen, Vivianne C. G.
    ANTI-CANCER DRUGS, 2006, 17 (08) : 881 - 889
  • [8] Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D
    Esther K. Lee
    William W. L. Wong
    Maureen E. Trudeau
    Kelvin K. W. Chan
    Breast Cancer Research and Treatment, 2015, 150 : 169 - 180
  • [9] Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level
    Baig, Hassam
    Somlo, Barbara
    Eisen, Melissa
    Stryker, Scott
    Bensink, Mark
    Morrow, Phuong K.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (07) : 1576 - 1585
  • [10] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    Kelly, S.
    Wheatley, D.
    BRITISH JOURNAL OF CANCER, 2009, 101 : S6 - S10